Effect of Implementing a Dashboard With or Without a Best Practice Alert on HLA ‐B*58:01 Testing Rates Among Allopurinol Users at VA Medical Centers
Authors' conclusion
Implementing a dashboard plus simple text BPA was associated with a greater increase in the proportion of patients who completed guideline-recommend HLA-B*58:01 testing compared to implementing a dashboard alone.
Study context
- Population
- Asian or African American/Black patients filling allopurinol prescriptions at two VA medical centers, October 2022–December 2023
- Participants
- 262 vs 330
- Comparison
- Clinician-facing dashboard plus best practice alert (BPA) vs dashboard only
- DASHBOARD + BPAn = 262
- DASHBOARD ONLYn = 330reference
- Outcome
- Change in proportion of patients prescribed allopurinol with HLA-B*58:01 testing before or during the month allopurinol was prescribed
- Follow-up
- October 2022 to December 2023
Methodological detailstwo-site comparison, difference-in-differences analysis, electronic health record data
- Two-site comparison
- Difference-in-differences analysis
- Electronic health record data
Main finding
As reported in the abstract
Asian or African American/Black patients with HLA-B*58:01 testing, October 2022 to December 2023
Asian or African American/Black patients with HLA-B*58:01 testing, October 2022 to December 2023
October 2022
- Dashboard + BPA vs Dashboard only: P < 0.0001 for difference in difference
Further findings
Cumulative % of prescribers whose patient(s) completed HLA-B*58:01 testing · December 2023
P < 0.0001 for difference in difference
Baseline
Original publication
Effect of Implementing a Dashboard With or Without a Best Practice Alert on HLA ‐B*58:01 Testing Rates Among Allopurinol Users at VA Medical Centers. Arthritis Care Res (Hoboken). Published 24 February 2026. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →